CGEM — Cullinan Therapeutics, Inc. stock price, charts and financials

QT91Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
21.08
-0.28-1.31%
OverviewShort InterestFilings
CGEMQT91Cullinan Therapeutics, Inc.·NASDAQ
21.08-1.31%
TA
Loading chart...
Short Interest History· Twice monthly
Settlement DateShort InterestAvg Daily VolumeShares FloatShort Float %Short Ratio
Aug-31-2610.37M913.58K44.16M23.49%11.35
Aug-14-2610.59M985.91K44.16M23.98%10.74
Jul-31-2610.25M1.05M44.16M23.22%9.77
Jul-15-2610.29M1.06M44.16M23.30%9.66
Jun-30-2610.60M1.08M44.16M24.00%9.79
Jun-15-268.19M969.58K44.16M18.54%8.44
May-29-267.97M877.29K44.16M18.06%9.09
May-15-268.68M854.55K44.16M19.66%10.16
Apr-30-268.80M789.59K44.16M19.93%11.14
Apr-15-268.11M800.04K44.16M18.38%10.14
Mar-31-268.39M788.41K44.16M19.01%10.65
Mar-13-268.36M828.54K44.16M18.94%10.10